CanSino coronavirus vaccine shows promise in mid-stage study
CanSino Coronavirus (Covid-19) Vaccine: The shot was shown to be safe and induced an immune response, according to a study released in the medical journal The Lancet, reinforcing the company’s status as a front-runner in the vaccine race.
No hay comentarios:
Publicar un comentario